References
- Ajay G, Boland CR (2012). Reviews in basic and clinical gastroenterology and hepatology. Gastroenterol, 143, 1442-60. https://doi.org/10.1053/j.gastro.2012.09.032
- Alory I, Soussan L, Seger R, Yarden Y (1999). Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol Cell Biol, 19, 1961-72.
- Block KL, Shou Y, Poncz M (1996). An Ets/Sp1 interaction in the 5'-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood, 88, 2071-80.
- Boag AH, Young ID (1994). Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. Am J Pathol, 144, 585-91.
- Boyle P, Ferlay J (2005). Cancer incidence and mortality in Europe. Ann Oncol, 16, 481-8. https://doi.org/10.1093/annonc/mdi098
- Clifford A, Beeuwkes R, Lainey L, Silverman KJ (1984). Hypothesis: vasa vasorum and neovascularization of human coronary arteries, a possible role in the pathophysiology of atherosclerosis. N Engl J Med, 310, 175-7. https://doi.org/10.1056/NEJM198401193100307
- Collins HM, Morris TM, Watson SA (2001). Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1 matrix metalloproteinase. Br J Cancer, 84, 1664-70. https://doi.org/10.1054/bjoc.2001.1831
- Elander N, Soderkvist P, Fransen K (2006). Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res, 26, 791-5.
- Enping X, Maode L, Bingjian L, et al (2004). A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun, 324, 999-1003. https://doi.org/10.1016/j.bbrc.2004.09.150
- Fang, J, Shing Y, Wiederschain D, et al (2000). Matrix metalloproteinase-2 required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA, 97, 3884-9. https://doi.org/10.1073/pnas.97.8.3884
- Flavia MG, Alisson MO, Riccardo L, et al (2013). Matrix metalloproteinase (MMP-2) gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura. Gene, 512, 35-40. https://doi.org/10.1016/j.gene.2012.09.109
- Gail W, Kevan H (2012). Clinical Update: colon, rectal, and anal cancers. Seminars in Oncology Nursing, 28, 1-22.
- Grieu F, Li WQ, Iacopetta B (2004). Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat, 8, 197-204.
- Heavey PM, McKenna D, Rowland IR (2004). Colorectal cancer and relationship between genes and the environment. Nutr Cancer, 48, 124-41. https://doi.org/10.1207/s15327914nc4802_2
- Hemminki K, Czene K (2002). Attributable risk of familial cancer from the family cancer database. Cancer Epidemiol Biomarkers Prev, 12, 1638-44.
- Itoh T, Tanioka M, Yoshida H, et al (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res, 58, 1048-51.
- Jormsjo S, Ye S, Moritz J, et al (2000). Allele specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res, 86, 998-1003. https://doi.org/10.1161/01.RES.86.9.998
- Laurie AS, Sandra JT, William GS (2012). Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol, 181, 1895-9. https://doi.org/10.1016/j.ajpath.2012.08.044
-
Lionel L, Abdelhabib S, Marc B, et al (2010). Crosstalk between T cells and bronchial fibroblasts obtained from asthmatic subjects involves CD40L/
${\alpha}5{\beta}1$ interaction. Mol Immunol, 47, 2112-8. https://doi.org/10.1016/j.molimm.2010.03.011 -
Loubaki L, Semlali A, Boisvert M, et al (2010). Crosstalk between T cells and bronchial fibroblasts obtained from asthmatic subjects involves CD40L/
${\alpha}5{\beta}1$ interaction. Mol Immunol, 47, 2112-8. https://doi.org/10.1016/j.molimm.2010.03.011 - Margana RK, Boggaram V (1997). Functional analysis of surfactant protein B (SP-B) promoter:Sp1, Sp3, TTF-1, and HNF-3a transcription factors are necessary for lung cell-specific activation of SP-B gene transcription. J Biol Chem, 272, 3083-90. https://doi.org/10.1074/jbc.272.5.3083
- Maouche L, Lucien N, Cartron JP, Chretien S (1995). A CCACC motif mediates negative transcriptional regulation of the human erythropoietin receptor. Eur J Biochem, 233, 793-9. https://doi.org/10.1111/j.1432-1033.1995.793_3.x
- Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al (1992). Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol, 141, 389-96.
- Potter JD (1999). Colorectal cancer: molecules and populations. J Natl Cancer Inst, 91, 916-32. https://doi.org/10.1093/jnci/91.11.916
- Price SJ, Greaves DR, Watkins H (2001). Identification of novel functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele specific transcriptional regulation. J Biol Chem, 276, 7549-58. https://doi.org/10.1074/jbc.M010242200
- Priyanka S, Tasleem AL, Rakesh K, Rama DM (2012). Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in north India. Arch Med Res, 43, 117-24. https://doi.org/10.1016/j.arcmed.2012.02.006
- Qin H, Sun Y, Benveniste EN (1999). The transcription factor Sp1, Sp3 and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem, 274, 29130-7. https://doi.org/10.1074/jbc.274.41.29130
- Roehe AV, Frazzon AP, Agnes G, et al (2007). Detection of polymorphisms in the promoter of matrix metalloproteinase 2 and 9 genes in breast cancer in South Brazil: preliminary results. Breast Cancer Res Treat, 102, 123-4. https://doi.org/10.1007/s10549-006-9273-1
- Rutter JL, Mitchell TI, Buttice G, et al (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res, 58, 5321-5.
- Sanger F, Nicklen S, Coulson A (1977). DNA sequencing with chain terminating inhibitor. Proc Natl Acad Sci USA, 74, 5463-7. https://doi.org/10.1073/pnas.74.12.5463
- Simon JP, David RG, Hugh W (2001). Identification of novel, functional genetic variants in the Human matrix metalloproteinase-2 gene. J Biol Chem, 276, 7549-58. https://doi.org/10.1074/jbc.M010242200
- Singer CF, Marbaix E, Kokorine I, et al (1997). Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1 alpha and its dual block by ovarian steroids. Proc Natl Acad Sci (USA), 94, 10341-5. https://doi.org/10.1073/pnas.94.19.10341
- Strongin AY, Collier I, Bannikov G, et al (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J Biol Chem, 270, 5331-8. https://doi.org/10.1074/jbc.270.10.5331
- Woessner JF (1998). In Matrix metalloproteinases (Parks, W.C., and Mecham, R.P., eds) pp. 1-14, Academic Press, Inc., San Diego, CA.
- Yihong H, Li S, Naqiong W, et al (2009). Polymorphisms of MMP-2 gene are associated with systolic heart failure prognosis. Clin Chim Acta, 404, 119-23. https://doi.org/10.1016/j.cca.2009.03.030
- Yrjo TK, Mia A, Heikki V, et al (1999). Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis, 58, 691-7. https://doi.org/10.1136/ard.58.11.691
- Zhou Y, Yu C, Miao X, et al (2004). Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitors of the matrix metalloproteinase-2 genes. Carcinogenesis, 25, 399-404.
Cited by
- Lack of Association Between the Matrix Metalloproteinase-2 -1306C>T Polymorphism and Breast Cancer Susceptibility: a Meta-analysis vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4823
- The MMP-2 -735 C Allele is a Risk Factor for Susceptibility to Breast Cancer vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6199
- Down-regulated MYH11 Expression Correlates with Poor Prognosis in Stage II and III Colorectal Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7223
- MMP2 Gene-735 C/T and MMP9 gene -1562 C/T Polymorphisms in JAK2V617F Positive Myeloproliferative Disorders vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.443
- Matrix Metalloproteinase-9 -1562T Allele and its Combination with MMP-2 -735 C Allele are Risk Factors for Breast Cancer vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1175
- Matrix Metalloproteinase-2 -1306 C>T Gene Polymorphism is Associated with Reduced Risk of Cancer: a Meta-analysis vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.889
- Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study vol.36, pp.5, 2015, https://doi.org/10.1007/s13277-014-3023-5
- Genetic variation of MMP-2(-735 C>T) and MMP-9(-1562 C>T) gene in risk of development of HAND and severity of HAND vol.18, pp.9, 2016, https://doi.org/10.1002/jgm.2897